Literature DB >> 8462795

Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease.

C P Choudari1, S O'Mahony, G Brydon, O Mwantembe, A Ferguson.   

Abstract

BACKGROUND: Fluid obtained by whole gut lavage normally contains traces of immunoglobulin (Ig) G, albumin, and alpha-1-antitrypsin; higher concentrations have been found in patients with inflammatory bowel disease (IBD).
METHODS: In a prospective study, 53 lavages were performed in 45 IBD patients (27 Crohn's disease, 18 ulcerative colitis), in whom disease activity was simultaneously assessed by Crohn's Disease Activity Index or Powell Tuck index. Concentration of IgG in lavage fluid was measured by enzyme-linked immunosorbent assay, and of albumin and alpha-1-antitrypsin by immunoturbidimetry.
RESULTS: For IgG, concentrations in lavage fluid correlated closely with activity indices: in Crohn's disease, r = 0.723 (P < 0.0001), in ulcerative colitis, r = 0.714 (P < 0.0001). Results for albumin and alpha-1-antitrypsin concentrations were similar to those for IgG, but they were less sensitive in detecting active disease. However, this method cannot be used as a diagnostic test for IBD; normal results were obtained for IgG in 6 (all inactive) of 42 lavages in patients who had unequivocal radiological or endoscopic abnormalities.
CONCLUSIONS: Assay of protein concentrations in gut lavage fluid is a simple, objective means of grading disease activity in patients with IBD; its potential uses are likely to be in the evaluation of complex cases and in clinical trials.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462795     DOI: 10.1016/0016-5085(93)90275-h

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.

Authors:  R Troncone; N Caputo; A Campanozzi; M Cucciardi; V Esposito; R Russo; B De Vizia; L Greco; S Cucchiara
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

Review 2.  Non-invasive investigation of inflammatory bowel disease.

Authors:  J A Tibble; I Bjarnason
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  Characterization of mucin in whole-gut lavage fluid obtained from patients with inflammatory bowel disease.

Authors:  H Saitoh; K Takagaki; T Nakamura; A Munakata; Y Yoshida; M Endo
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

4.  Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading.

Authors:  A Ferguson; K A Humphreys; N M Croft
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

Review 5.  Mucosal immunology research design should address not just cytokines and cells, but also clinical data and controls.

Authors:  S Ghosh; A Ferguson
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

6.  Intestinal inflammation in cystic fibrosis.

Authors:  R L Smyth; N M Croft; U O'Hea; T G Marshall; A Ferguson
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

7.  Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ.

Authors:  Y Z Almallah; S W Ewen; A El-Tahir; N A Mowat; P W Brunt; T S Sinclair; S D Heys; O Eremin
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

8.  A simple method for assessing intestinal inflammation in Crohn's disease.

Authors:  J Tibble; K Teahon; B Thjodleifsson; A Roseth; G Sigthorsson; S Bridger; R Foster; R Sherwood; M Fagerhol; I Bjarnason
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

9.  Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.

Authors:  A Macpherson; U Y Khoo; I Forgacs; J Philpott-Howard; I Bjarnason
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

Review 10.  Rectal effluent as a research tool.

Authors:  Jana M Rocker; Jack A DiPalma; Lewis K Pannell
Journal:  Dig Dis Sci       Date:  2014-09-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.